August 21, 2026

We learned yesterday that Tim’s PSA count continues to rise. The current number is 192. He is actually feeling pretty good.

The footnote has some of the information I found about that number:*

After reading all this stuff, Tim and I decided to continue with the Ivermectin, Fenbendazole, supplements and foods that are reported to fight cancer.

Tim and I know that our lives are in the hands of God. Our days are numbered—all of them are written in his book. We will work to maintain the best quality of life possible for Tim without putting his body through the trauma of drugs, surgeries, radiation, and  chemical assaults.

Scripture that confirms that God has our days numbered:

The days of our lives add up to seventy years,
or eighty, if one is especially strong.
But even one’s best years are marred by trouble and oppression.
Yes, they pass quickly and we fly away.
Psalms 90:10

So teach us to consider our mortality,
so that we might live wisely.
Psalms 90:12

Psalm 139:16 

Your eyes saw me when I was inside the womb.
All the days ordained for me
were recorded in your scroll
before one of them came into existence.
Psalms 139:16

“O LORD, help me understand my mortality
and the brevity of life.
Let me realize how quickly my life will pass.
Look, you make my days short-lived,
and my life span is nothing from your perspective.
Surely all people, even those who seem secure, are nothing but vapor.
Psalms 39:4-5

I was once young, now I am old.
I have never seen the godly abandoned,
or their children forced to search for food.
All day long they show compassion and lend to others,
and their children are blessed.
Turn away from evil. Do what is right.
Then you will enjoy lasting security.
For the LORD promotes justice,
and never abandons his faithful followers.
They are permanently secure,
Psalms 37:25-28

Job 14:5: “Since his days are determined and the number of his months is with You, and since You have set limits that he cannot exceed.”

Daniel 5:26 “God has numbered the days of your reign and has brought it to an end.”

Man is like a puff of wind, his days like a fleeting shadow.
Psalms 144:4

You don’t even know if you will be alive tomorrow! For all you are is a mist that appears for a little while and then disappears.
James 4:14

In the Gospels, Jesus teaches that the length of human life is fixed by God and cannot be extended by human effort or worry.  He emphasizes that life is a temporary gift that God can require at any moment. 

Matthew 6:27: “Can any one of you by worrying add a single hour to your life?” 

Top of Form

Psalm 139:16 Your eyes saw my unformed substance; in your book were written, every one of them, the days that were formed for me, when as yet there was none of them.

Job 14:5 Since his days are determined, and the number of his months is with you, and you have appointed his limits that he cannot pass,

Psalm 90:12 So teach us to number our days that we may get a heart of wisdom.

Job 14:1-6 Man who is born of a woman is few of days and full of trouble. He comes out like a flower and withers; he flees like a shadow and continues not. And do you open your eyes on such a one and bring me into judgment with you? Who can bring a clean thing out of an unclean? There is not one. Since his days are determined, and the number of his months is with you, and you have appointed his limits that he cannot pass, …

Bottom of Form

Luke 12:20: “You fool! This very night your life will be demanded from you. Then who will get what you have prepared for yourself?”

Deuteronomy 32:39 See now that I, yes, I, am he;
and there is no god beside me.
I put to death, and I make alive;
I wound, and I heal;
no one saves anyone from my hand!

Philippians 1:21 For to me, life is the Messiah, and death is gain.

 Philippians 3:20-21 But we are citizens of heaven, and it is from there that we expect a Deliverer, the Lord Yeshua the Messiah. He will change the bodies we have in this humble state and make them like his glorious body, using the power which enables him to bring everything under his control.

John 11:25-26 Yeshua said to her, “I AM the Resurrection and the Life! Whoever puts his trust in me will live, even if he dies; and everyone living and trusting in me will never die. Do you believe this?

John 14:6-11 Yeshua said, “I AM the Way—and the Truth and the Life; no one comes to the Father except through me. Because you have known me, you will also know my Father; from now on, you do know him—in fact, you have seen him.”
Philip said to him, “Lord, show us the Father, and it will be enough for us.” Yeshua replied to him, “Have I been with you so long without your knowing me, Philip? Whoever has seen me has seen the Father; so how can you say, ‘Show us the Father’? Don’t you believe that I am united with the Father, and the Father united with me? What I am telling you, I am not saying on my own initiative; the Father living in me is doing his own works. Trust me, that I am united with the Father, and the Father united with me.

Footnote:

*A PSA count of 192 ng/mL indicates a critically high elevation that is a very strong indicator of advanced prostate cancer. 

• Clinical Significance: Levels above 50 ng/mL are typically not caused by infection or benign conditions like an enlarged prostate; they strongly suggest malignancy. 
• Risk of Spread: A PSA level exceeding 20 ng/mL is associated with a high probability of metastatic disease (cancer that has spread to bones or other organs). 
• Immediate Action: This result requires urgent urologic evaluation and staging workup to determine the extent of the disease. 

A PSA count of 192 ng/mL is an extremely high value that almost always indicates advanced prostate cancer with a very high probability of metastasis (spread to other parts of the body, particularly bones). 

Clinical Implications

• High Probability of Metastasis: Research indicates that for PSA levels above 100 ng/mL, the risk of metastatic disease is approximately 87.5%.  A PSA of 192 ng/mL places the patient in a category where the cancer has likely spread beyond the prostate gland.
• Prognosis: Men presenting with PSA levels over 100 ng/mL have significantly reduced survival rates compared to those with lower levels. Five-year overall survival rates for this group are approximately 29.1%, compared to 62.5% for those with PSA levels between 20–100 ng/mL. 
• Not Benign: While benign conditions like an enlarged prostate (BPH) or infection (prostatitis) can elevate PSA, they rarely cause levels to exceed 50 ng/mL, and almost never reach 192 ng/mL. At this level, malignancy is the primary concern. 

Immediate Diagnostic Steps

A PSA of 192 requires urgent and comprehensive staging to determine the extent of the disease:

1. Imaging:
   • PSMA PET/CT Scan: This is the most sensitive imaging test currently available for detecting prostate cancer metastases. It is highly recommended for initial staging in high-risk patients.
   • Bone Scan: To specifically check for cancer spread to the bones, which is common at this PSA level.
   • MRI of the Prostate: To evaluate the primary tumor within the prostate and surrounding tissues.
   • CT Scan: To check for spread to lymph nodes and other organs.
2. Biopsy: A prostate biopsy is necessary to confirm the diagnosis and determine the Gleason score (grade) of the cancer, which is a critical factor in prognosis and treatment planning alongside the PSA level and metastatic status. 
3. Blood Work: Comprehensive blood tests, including testosterone levels, alkaline phosphatase (a marker for bone activity), and complete blood counts, are standard.

• Treatment Outlook

• While a PSA of 192 indicates advanced disease, it is treatable.  The primary treatment for metastatic prostate cancer is Androgen Deprivation Therapy (ADT), which lowers testosterone levels to starve the cancer. Recent studies show that achieving a PSA drop to below 0.2 ng/mL within the first 9 months of treatment is a strong indicator of improved survival. 

Androgen Deprivation Therapy (ADT) works by drastically lowering testosterone, which effectively treats prostate cancer but causes systemic side effects affecting nearly every organ system.  These are categorized into immediate quality-of-life issues and serious long-term health risks.

Common Physical & Quality of Life Side Effects

These symptoms often appear early in treatment and can significantly impact daily living:

• Vasomotor Symptoms: Hot flashes and night sweats are the most common complaint, affecting 68–80% of men.  These can be severe and disrupt sleep.
• Sexual Dysfunction: Nearly all patients experience a loss of libido (54–97% incidence) and erectile dysfunction (72–80% incidence).  Unlike surgery, these effects are directly tied to the lack of testosterone and typically do not improve with standard ED medications like Viagra while on ADT.
• Fatigue & Anemia: Profound tiredness is reported by most patients, often exacerbated by anemia (low red blood cell count) caused by testosterone suppression. 
• Body Composition Changes: Patients typically experience muscle loss (sarcopenia) and an increase in body fat, particularly around the abdomen.  This shift contributes to weight gain and reduced physical strength.
• Gynecomastia: Breast tissue enlargement and tenderness occur in a significant portion of patients, particularly those treated with certain anti-androgens. 

Ivermectin and fenbendazole are not approved treatments for prostate cancer, and their use remains experimental and unproven outside of clinical trials.  While there is significant anecdotal interest and emerging case series data as of 2026, major medical organizations do not yet endorse them as standard care. 

Current Evidence Status (2026)

The evidence for these repurposed antiparasitic drugs consists primarily of preclinical studies and anecdotal case reports, lacking the validation of large-scale randomized controlled trials (RCTs). 

• Case Series Data: Recent compilations (e.g., the “One Day MD” and “Aesthetics Advisor” series updated in mid-2026) describe over 130 patients who reportedly experienced dramatic PSA reductions (e.g., >90% drops) and radiological improvements (resolution of bone/lymph node metastases) using combinations of ivermectin (1–1.5 mg/kg/day) and fenbendazole (1,000–2,000 mg/day).
  • Some reports claim patients achieved “no evidence of disease” (NED) or avoided chemotherapy.
  • Critical Limitation: These reports suffer from selection bias and confounding variables.  Most patients were simultaneously receiving standard treatments like Androgen Deprivation Therapy (ADT), abiraterone, or chemotherapy, making it impossible to attribute the improvement solely to the antiparasitics.
• Preclinical Mechanisms: Laboratory studies suggest plausible biological mechanisms, such as disrupting microtubules (fenbendazole) or inhibiting specific cancer pathways (ivermectin), which can kill prostate cancer cells in petri dishes. However, success in cell cultures does not guarantee efficacy in humans. 
• Lack of Regulatory Approval: The FDA and NCI have not approved either drug for cancer treatment.  The NCCN Guidelines (the standard for oncology care) do not currently include them as recommended therapies. 

Safety and Risks

While generally considered safe for their approved antiparasitic uses, high-dose or long-term use for cancer carries risks:

• Fenbendazole: Not approved for human use in many jurisdictions (it is a veterinary drug). Reports of hepatotoxicity (liver injury) and neuropathy exist in anecdotal cancer communities.  Purity and dosage of veterinary formulations are not regulated for human consumption.
• Ivermectin: Approved for humans but can cause toxicity at high doses, including neurological side effects. It also has potential drug interactions with standard cancer medications (e.g., via CYP3A4 enzyme pathways), which could alter the effectiveness or toxicity of prescribed therapies. 
• False Hope & Delay: Relying on unproven therapies may lead patients to delay or forego proven treatments (like ADT, novel hormonal agents, or radioligand therapy), potentially allowing the cancer to progress unchecked.